Intrinsic value of Sonnet BioTherapeutics Holdings, Inc. (SONN)
Live fair value data for Sonnet BioTherapeutics Holdings, Inc. (SONN) is currently unavailable. Please check again shortly.
Current Price: $448.00
Valuation: Undervalued
Confidence: 5.0/10
Visual Bar
This intrinsic value is calculated using 5 different models based on projected revenue growth, profit margins, and a standard discount rate.
Is Sonnet BioTherapeutics Holdings, Inc. (SONN) undervalued or overvalued?
Based on the current model output, Sonnet BioTherapeutics Holdings, Inc. appears to be undervalued with a upside of 11.00%.
Fair value vs market price — Sonnet BioTherapeutics Holdings, Inc. (SONN)
Unlock premium access to view the live fair value comparison against current market price for SONN.
Frequently Asked Questions - SONN
How is SONN intrinsic value estimated?
We combine revenue growth, discount rate, and terminal growth assumptions to estimate a fair value range for SONN.
Is SONN undervalued or overvalued right now?
SONN is currently shown as undervalued based on the difference between market price and intrinsic value.
How should I use the confidence score?
The confidence score (0 to 10) indicates model certainty from available inputs. Higher values suggest stronger model consistency, not a guarantee of returns.
Related companies — intrinsic value
Peers for SONN: open their intrinsic value pages.